However, the proportion of anti-MART1 T cells in melanoma was higher than anti-PR1 T cells in CML suggesting that not all tumor-associated antigens generate similar responses, warranting the search for other leukemia-associated antigens and their TCRs in CML. Here, TMEM37 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.